VERTEX PHARMACEUTICALS INC / MA Current Liabilities 2009-2026 | VRTX
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is VERTEX PHARMACEUTICALS INC / MA's current current liabilities?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual current liabilities for 2025 was $3.86B, a 8.32% increase from 2024. VERTEX PHARMACEUTICALS INC / MA current liabilities for the quarter ending March 31, 2026 was $3.88B.
What was VERTEX PHARMACEUTICALS INC / MA's current liabilities in 2024?
VERTEX PHARMACEUTICALS INC / MA annual current liabilities for 2024 was $3.56B, a 0.48% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's current liabilities in 2023?
VERTEX PHARMACEUTICALS INC / MA annual current liabilities for 2023 was $3.55B, a 29.37% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year current liabilities CAGR?
VERTEX PHARMACEUTICALS INC / MA current liabilities grew at a compound annual growth rate (CAGR) of 15.51% from FY2020 to FY2025, going from $1.88B to $3.86B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.86B | +8.3% | 10-K |
| FY2024 | $3.56B | +0.5% | 10-K |
| FY2023 | $3.55B | +29.4% | 10-K |
| FY2022 | $2.74B | +28.0% | 10-K |
| FY2021 | $2.14B | +14.1% | 10-K |
| FY2020 | $1.88B | +40.7% | 10-K |
| FY2019 | $1.33B | +19.1% | 10-K |
| FY2018 | $1.12B | +38.8% | 10-K |
| FY2017 | $807.3M | +1.9% | 10-K |
| FY2016 | $792.5M | +56.6% | 10-K |
| FY2015 | $506.2M | +37.5% | 10-K |
| FY2014 | $368.3M | -7.4% | 10-K |
| FY2013 | $397.8M | -8.0% | 10-K |
| FY2012 | $432.6M | +10.3% | 10-K |
| FY2011 | $392.3M | -17.4% | 10-K |
| FY2010 | $474.8M | +66.7% | 10-K |
| FY2009 | $284.9M | - | 10-K |